The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Antibiotic Resistance and the MRSA Problem
Open accessAbstract
Staphylococcus aureus is capable of becoming resistant to all classes of antibiotics clinically available and resistance can develop through de novo mutations in chromosomal genes or through acquisition of horizontally transferred resistance determinants. This review covers the most important antibiotics available for treatment of S. aureus infections and a special emphasis is dedicated to the current knowledge of the wide variety of resistance mechanisms that S. aureus employ to withstand antibiotics. Since resistance development has been inevitable for all currently available antibiotics, new therapies are continuously under development. Besides development of new small molecules affecting cell viability, alternative approaches including anti-virulence and bacteriophage therapeutics are being investigated and may become important tools to combat staphylococcal infections in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The increasing prevalence of fluoroquinolone resistance in S. aureus, particularly MRSA, presents significant challenges in clinical settings.”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [238]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–253 of 253
Scharn, C. R., Tenover, F. C., & Goering, R. V. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01058-13 · Cited by 79
Lincosamides: Chemical Structure, Biosynthesis, Mechanism of Action, Resistance, and Applications
Spížek, J., Novotná, J., & Řezanka, T. (2004) · Advances in applied microbiology · doi:10.1016/s0065-2164(04)56004-5 · Cited by 78
Kosowska-Shick, K., Clark, C. L., Credito, K. L., McGhee, P., Dewasse, B. E., Bogdanovich, T., & Appelbaum, P. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.765-769.2006 · Cited by 78
Bæk, K. T., Thøgersen, L., Mogensen, R. G., Mellergaard, M., Thomsen, L. E., Petersen, A., Skov, S., Cameron, D. R., Peleg, A. Y., & Frees, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01303-15 · Cited by 77
Self-citationYang, L. P. H., & Keam, S. J. (2008) · Drugs · doi:10.2165/00003495-200868060-00008 · Cited by 76
Roberts, G. A., Houston, P. J., White, J. H., Chen, K., Stephanou, A. S., Cooper, L. P., Dryden, D. T. F., & Lindsay, J. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt535 · Cited by 76
Kriegeskorte, A., Lorè, N. I., Bragonzi, A., Riva, C., Kelkenberg, M., Becker, K., Proctor, R. A., Peters, G., & Kahl, B. C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00742-15 · Cited by 75
The ClpXP protease is dispensable for degradation of unfolded proteins in Staphylococcus aureus
Stahlhut, S. G., Alqarzaee, A. A., Jensen, C., Fisker, N. S., Pereira, A. R., Pinho, M. G., Thomas, V. C., & Frees, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-12122-y · Cited by 74
Self-citationİnce, D., & Hooper, D. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2755-2764.2001 · Cited by 71
Boundy, S., Safo, M. K., Wang, L., Musayev, F. N., O′Farrell, H. C., Rife, J. P., & Archer, G. L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.385138 · Cited by 70
Gentry, D. R., McCloskey, L., Gwynn, M. N., Rittenhouse, S. F., Scangarella, N., Shawar, R. M., & Holmes, D. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00915-08 · Cited by 70
Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics
Roemer, T., Schneider, T., & Pinho, M. G. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.012 · Cited by 69
Ortwine, J. K., Werth, B. J., Sakoulas, G., & Rybak, M. J. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2013.10.002 · Cited by 69
Reversible Antibiotic Tolerance Induced in Staphylococcus aureus by Concurrent Drug Exposure
Haaber, J., Friberg, C., McCreary, M., Lin, R., Cohen, S. N., & Ingmer, H. (2015) · mBio · doi:10.1128/mbio.02268-14 · Cited by 69
Self-citationSelection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus by Imipenem
Katayama, Y., Murakami-Kuroda, H., Cui, L., & Hiramatsu, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-08 · Cited by 68
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Gould, I. M., Cauda, R., Esposito, S., Gudiol, F., Mazzei, T., & Garau, J. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.030 · Cited by 66
Reversal of methicillin resistance in Staphylococcus aureus by thioridazine
Klitgaard, J. K., Skov, M. N., Kallipolitis, B. H., & Kolmos, H. J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn417 · Cited by 66
Cafini, F., Nguyen, L. T. T., Higashide, M., Román, F., Prieto, J., & Morikawa, K. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv391 · Cited by 65
Transfer of the methicillin resistance genomic island among staphylococci by conjugation
Ray, M. D., Boundy, S., & Archer, G. L. (2016) · Molecular Microbiology · doi:10.1111/mmi.13340 · Cited by 65
Bayer, A. S., Mishra, N. N., Sakoulas, G., Nonejuie, P., Nast, C. C., Pogliano, J., Chen, K.-T., Ellison, S., Yeaman, M. R., & Yang, S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03422-14 · Cited by 63
Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections
Zhanel, G. G., Trapp, S., Gin, A. S., DeCorby, M. R., Lagacé-Wiens, P. R. S., Rubinstein, E., Hoban, D. J., & Karlowsky, J. A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.1.67 · Cited by 63
Ribosome clearance by FusB-type proteins mediates resistance to the antibiotic fusidic acid
Cox, G., Thompson, G. S., Jenkins, H. T., Peske, F., Savelsbergh, A., Rodnina, M. V., Wintermeyer, W., Homans, S. W., Edwards, T. A., & O’Neill, A. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117275109 · Cited by 58
Norlichexanthone Reduces Virulence Gene Expression and Biofilm Formation in Staphylococcus aureus
Baldry, M., Nielsen, A., Bojer, M. S., Zhao, Y., Friberg, C., Ifrah, D., Heede, N. G., Larsen, T. O., Frøkiær, H., Frees, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168305 · Cited by 58
Self-citationRoch, M., Clair, P., Renzoni, A., Reverdy, M. E., Dauwalder, O., Bes, M., Martra, A., Freydière, A.-M., Laurent, F. J., Reix, P., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02574-14 · Cited by 53
Garza‐González, E., Llaca-Díaz, J. M., Bosques‐Padilla, F., et al. (2010) · Chemotherapy · doi:10.1159/000319903 · Cited by 51
Severin, A. I., Wu, S. W., Tabei, K., & Tomasz, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4566-4573.2004 · Cited by 51
de LENCASTRE, H., Chung, M., & Westh, H. (2000) · Microbial Drug Resistance · doi:10.1089/mdr.2000.6.1 · Cited by 49
Larsen, J., Clasen, J., Hansen, J. E., Paulander, W., Petersen, A., Larsen, A. R., & Frees, D. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00426-16 · Cited by 48
Self-citationSader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02684-13 · Cited by 47
Vidaillac, C., Gardete, S., Tewhey, R., Sakoulas, G., Kaatz, G. W., Rose, W. E., Tomasz, A., & Rybak, M. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit127 · Cited by 45
Antignac, A., & Tomasz, A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01099-08 · Cited by 44
Chlebowicz, M. A., Mašlaňová, I., Kuntová, L., Grundmann, H., Pantůček, R., Doškař, J., van Dijl, J. M., & Buist, G. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.05.010 · Cited by 44
Tsakris, A., Pillai, S. K., Gold, H. S., Thauvin-Eliopoulos, C., Venkataraman, L., Wennersten, C. B., Moellering, R. C., & Eliopoulos, G. M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm246 · Cited by 43
Predominance of dfrG as determinant of trimethoprim resistance in imported Staphylococcus aureus
Nurjadi, D., Schäfer, J., Friedrich-Jänicke, B., Müeller, A., Neumayr, A. L. C., Cano, A. C., Goorhuis, A., Molhoek, N., Lagler, H., Kantele, A., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.08.021 · Cited by 42
Molecular cloning and mapping of 16S-23S rRNA gene complexes of Staphylococcus aureus
Wada, A., Ohta, H., Kulthanan, K., & Hiramatsu, K. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7483-7487.1993 · Cited by 40
Yoo, J. I., Kim, J. W., Kang, G. S., Kim, H. S., Yoo, J. S., & Lee, Y. S. (2013) · The Journal of Microbiology · doi:10.1007/s12275-013-3088-7 · Cited by 40
Small-Molecule Potentiators for Conventional Antibiotics against Staphylococcus aureus
Vermote, A., & Calenbergh, S. V. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00084 · Cited by 40
Besier, S. M., Zander, J., Siegel, E., Saum, S. H., Hunfeld, K., Ehrhart, A., Brade, V., & Wichelhaus, T. A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01440-08 · Cited by 38
Renzoni, A., Kelley, W. L., Barras, C., Monod, A., Huggler, E., François, P., Schrenzel, J., Studer, R., Vaudaux, P. E., & Lew, D. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01287-08 · Cited by 38
Vickers, A. A., Potter, N. J., Fishwick, C. W. G., Chopra, I., & O’Neill, A. J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp090 · Cited by 38
Dabul, A. N. G., Avaca-Crusca, J. S., Tyne, D. V., Gilmore, M. S., & Camargo, I. L. B. D. C. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0279 · Cited by 38
Wi, Y. M., Kim, J. M., Joo, E., Ha, Y. E., Kang, C., Ko, K. S., Chung, D. R., Song, J., & Peck, K. R. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.04.003 · Cited by 33
Kang, K.-M., Mishra, N. N., Park, K. T., Lee, G. Y., Park, Y. H., Bayer, A. S., & Yang, S. (2017) · The Journal of Microbiology · doi:10.1007/s12275-017-6509-1 · Cited by 33
Donegan, N. P., Marvin, J. S., & Cheung, A. L. (2014) · Journal of Bacteriology · doi:10.1128/jb.02222-14 · Cited by 32
Genetic Complexity of Fusidic Acid-Resistant Small Colony Variants (SCV) in Staphylococcus aureus
Lannergård, J., Cao, S., Norström, T., Delgado, A., Gustafson, J. E., & Hughes, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028366 · Cited by 30
Wang, J., Lai, C.-H., Lin, H.-H., Chen, W.-F., Shih, Y.-C., & Hung, C. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.07.010 · Cited by 26
Cameron, D. R., Lin, Y.-H., Trouillet‐Assant, S., Dyon-Tafani, V., Kostoulias, X., Mouhtouris, E., Skinner, N. A., Visvanathan, K., Baines, S. L., Howden, B. P., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.03.027 · Cited by 25
Bal, A. M., Garau, J., Gould, I. M., Liao, C., Mazzei, T., Nimmo, G. R., Soriano, À., Stefani, S., & Tenover, F. C. (2013) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2013.01.002 · Cited by 22
Le, V. T. M., Le, H. N., Pinheiro, M. G., Hahn, K. J., Dinh, M. L., Larson, K. B., Flanagan, S. D., Badiou, C., Lina, G., Tkaczyk, C., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02734-16 · Cited by 20
Global analysis of the impact of linezolid onto virulence factor production in S. aureus USA300
Bonn, F., Pané‐Farré, J., Schlüter, R., Schaffer, M., Fuchs, S., Bernhardt, J., Riedel, K., Otto, A., Völker, U., van Dijl, J. M., et al. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.02.004 · Cited by 15
First report of linezolid dependence in methicillin-resistant Staphylococcus aureus
López-Hernández, I., Delgado-Valverde, M., Díaz, N. B., & Pascual, Á. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.03.012 · Cited by 11
Frees, D., Thøgersen, L., Petersen, A., Paulander, W., Bæk, K. T., Gründling, A., & Mogensen, R. G. (2014) · Cited by 2
Self-citation(2017) · PubMed Central
Cited by
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus
Guo, Y., Song, G., Sun, M., Wang, J., & Wang, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00107 · Cited by 870
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Silva, K. P. T., Sundar, G., & Khare, A. (2023) · Nature Communications · doi:10.1038/s41467-023-38507-4 · Cited by 44
de Souza, A. Á., Lima, A. M., dede Oliveira BezerraSousa, D., Nogueira, F. C., do Sacramento Neto, J. C., Dias, L. P., Araújo, N. M. S., Nagano, C. S., Júnior, H. V. N., da Silva, C. R., et al. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09979-5 · Cited by 8
Metadata
- Authors
- Vestergaard, M., Frees, D., & Ingmer, H.
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2019-04-12
- Volume
- 7
- Issue
- 2
- ISSN
- 2165-0497 (ISSN-L)
- OpenAlex
- W2923656972
- Cited by
- 490
- References
- 253
- FWCI
- 24.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.